1. Current and Future Cardiovascular PET Radiopharmaceuticals
- Author
-
Uzair S. Ismailani, Benjamin H. Rotstein, and Rami Al-Haddad
- Subjects
medicine.medical_specialty ,Coronary Artery Disease ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,Coronary Circulation ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Pet tracer ,Radioisotopes ,Radiation ,Fatty acid metabolism ,business.industry ,Fatty Acids ,General Medicine ,Pet imaging ,Blood flow ,Plaque, Atherosclerotic ,Autonomic nervous system ,chemistry ,Autonomic Nervous System Diseases ,Cardiovascular Diseases ,030220 oncology & carcinogenesis ,Positron-Emission Tomography ,Cardiology ,Radiopharmaceuticals ,business ,Forecasting - Abstract
PET imaging is a continuously developing clinical tool for the imaging of different markers of cardiovascular diseases. In this article, some important PET tracers for several diseases affecting the heart and the vessels are highlighted; these include myocardial blood flow, atherosclerosis, fatty acid metabolism, and pathologies in the cardiac autonomic nervous system.
- Published
- 2019